Cargando…

Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline

As multidrug-resistant pathogens emerge and spread rapidly, novel antibiotics urgently need to be discovered. With a dwindling antibiotic pipeline, antibiotic adjuvants might be used to revitalize existing antibiotics. In recent decades, traditional Chinese medicine has occupied an essential positio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuhang, Su, Junfeng, Zhou, Ziyan, Yang, Jie, Liu, Wenjuan, Zhang, Yafen, Zhang, Pengyu, Guo, Tingting, Li, Guocai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269726/
https://www.ncbi.nlm.nih.gov/pubmed/37070985
http://dx.doi.org/10.1128/spectrum.04702-22
_version_ 1785059235169566720
author Wang, Yuhang
Su, Junfeng
Zhou, Ziyan
Yang, Jie
Liu, Wenjuan
Zhang, Yafen
Zhang, Pengyu
Guo, Tingting
Li, Guocai
author_facet Wang, Yuhang
Su, Junfeng
Zhou, Ziyan
Yang, Jie
Liu, Wenjuan
Zhang, Yafen
Zhang, Pengyu
Guo, Tingting
Li, Guocai
author_sort Wang, Yuhang
collection PubMed
description As multidrug-resistant pathogens emerge and spread rapidly, novel antibiotics urgently need to be discovered. With a dwindling antibiotic pipeline, antibiotic adjuvants might be used to revitalize existing antibiotics. In recent decades, traditional Chinese medicine has occupied an essential position in adjuvants of antibiotics. This study found that baicalein potentiates doxycycline against multidrug-resistant Gram-negative pathogens. Mechanism studies have shown that baicalein causes membrane disruption by attaching to phospholipids on the Gram-negative bacterial cytoplasmic membrane and lipopolysaccharides on the outer membrane. This process facilitates the entry of doxycycline into bacteria. Through collaborative strategies, baicalein can also increase the production of reactive oxygen species and inhibit the activities of multidrug efflux pumps and biofilm formation to potentiate antibiotic efficacy. Additionally, baicalein attenuates the lipopolysaccharide-induced inflammatory response in vitro. Finally, baicalein can significantly improve doxycycline efficacy in mouse lung infection models. The present study showed that baicalein might be considered a lead compound, and it should be further optimized and developed as an adjuvant that helps combat antibiotic resistance. IMPORTANCE Doxycycline is an important broad-spectrum tetracycline antibiotic used for treating multiple human infections, but its resistance rates are recently rising globally. Thus, new agents capable of boosting the effectiveness of doxycycline need to be discovered. In this study, it was found that baicalein potentiates doxycycline against multidrug-resistant Gram-negative pathogens in vitro and in vivo. Due to its low cytotoxicity and resistance, the combination of baicalein and doxycycline provides a valuable clinical reference for selecting more effective therapeutic strategies for treating infections caused by multidrug-resistant Gram-negative clinical isolates.
format Online
Article
Text
id pubmed-10269726
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-102697262023-06-16 Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline Wang, Yuhang Su, Junfeng Zhou, Ziyan Yang, Jie Liu, Wenjuan Zhang, Yafen Zhang, Pengyu Guo, Tingting Li, Guocai Microbiol Spectr Research Article As multidrug-resistant pathogens emerge and spread rapidly, novel antibiotics urgently need to be discovered. With a dwindling antibiotic pipeline, antibiotic adjuvants might be used to revitalize existing antibiotics. In recent decades, traditional Chinese medicine has occupied an essential position in adjuvants of antibiotics. This study found that baicalein potentiates doxycycline against multidrug-resistant Gram-negative pathogens. Mechanism studies have shown that baicalein causes membrane disruption by attaching to phospholipids on the Gram-negative bacterial cytoplasmic membrane and lipopolysaccharides on the outer membrane. This process facilitates the entry of doxycycline into bacteria. Through collaborative strategies, baicalein can also increase the production of reactive oxygen species and inhibit the activities of multidrug efflux pumps and biofilm formation to potentiate antibiotic efficacy. Additionally, baicalein attenuates the lipopolysaccharide-induced inflammatory response in vitro. Finally, baicalein can significantly improve doxycycline efficacy in mouse lung infection models. The present study showed that baicalein might be considered a lead compound, and it should be further optimized and developed as an adjuvant that helps combat antibiotic resistance. IMPORTANCE Doxycycline is an important broad-spectrum tetracycline antibiotic used for treating multiple human infections, but its resistance rates are recently rising globally. Thus, new agents capable of boosting the effectiveness of doxycycline need to be discovered. In this study, it was found that baicalein potentiates doxycycline against multidrug-resistant Gram-negative pathogens in vitro and in vivo. Due to its low cytotoxicity and resistance, the combination of baicalein and doxycycline provides a valuable clinical reference for selecting more effective therapeutic strategies for treating infections caused by multidrug-resistant Gram-negative clinical isolates. American Society for Microbiology 2023-04-18 /pmc/articles/PMC10269726/ /pubmed/37070985 http://dx.doi.org/10.1128/spectrum.04702-22 Text en Copyright © 2023 Wang et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Wang, Yuhang
Su, Junfeng
Zhou, Ziyan
Yang, Jie
Liu, Wenjuan
Zhang, Yafen
Zhang, Pengyu
Guo, Tingting
Li, Guocai
Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline
title Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline
title_full Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline
title_fullStr Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline
title_full_unstemmed Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline
title_short Baicalein Resensitizes Multidrug-Resistant Gram-Negative Pathogens to Doxycycline
title_sort baicalein resensitizes multidrug-resistant gram-negative pathogens to doxycycline
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269726/
https://www.ncbi.nlm.nih.gov/pubmed/37070985
http://dx.doi.org/10.1128/spectrum.04702-22
work_keys_str_mv AT wangyuhang baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline
AT sujunfeng baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline
AT zhouziyan baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline
AT yangjie baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline
AT liuwenjuan baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline
AT zhangyafen baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline
AT zhangpengyu baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline
AT guotingting baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline
AT liguocai baicaleinresensitizesmultidrugresistantgramnegativepathogenstodoxycycline